R25	Appositive Attribute:T472 Head:T19
R26	Appositive Attribute:T472 Head:T17
R27	Appositive Attribute:T472 Head:T47
R28	Anaphora Anaphor:T474 Antecedent:T19
R29	Anaphora Anaphor:T474 Antecedent:T17
R30	Anaphora Anaphor:T474 Antecedent:T47
R31	Anaphora Anaphor:T478 Antecedent:T24
R32	Anaphora Anaphor:T478 Antecedent:T24
R33	Anaphora Anaphor:T479 Antecedent:T377
R34	Anaphora Anaphor:T533 Antecedent:T56
R35	Anaphora Anaphor:T546 Antecedent:T545
R36	Anaphora Anaphor:T557 Antecedent:T559
R37	Anaphora Anaphor:T574 Antecedent:T142
R38	Anaphora Anaphor:T574 Antecedent:T142
R39	Anaphora Anaphor:T581 Antecedent:T420
R40	Anaphora Anaphor:T581 Antecedent:T431
R41	Anaphora Anaphor:T581 Antecedent:T438
R42	Anaphora Anaphor:T603 Antecedent:T421
R43	Anaphora Anaphor:T603 Antecedent:T432
R44	Anaphora Anaphor:T603 Antecedent:T439
R45	Anaphora Anaphor:T627 Antecedent:T632
R46	Anaphora Anaphor:T636 Antecedent:T197
R47	Anaphora Anaphor:T635 Antecedent:T204
R48	Anaphora Anaphor:T641 Antecedent:T233
R49	Anaphora Anaphor:T640 Antecedent:T241
R50	Anaphora Anaphor:T680 Antecedent:T306
R51	Anaphora Anaphor:T680 Antecedent:T304
R52	Anaphora Anaphor:T680 Antecedent:T311
R53	Anaphora Anaphor:T680 Antecedent:T301
R54	Anaphora Anaphor:T680 Antecedent:T308
R55	Anaphora Anaphor:T680 Antecedent:T314
R56	Anaphora Anaphor:T680 Antecedent:T303
R57	Anaphora Anaphor:T680 Antecedent:T33
R58	Anaphora Anaphor:T680 Antecedent:T35
R59	Anaphora Anaphor:T680 Antecedent:T32
R60	Anaphora Anaphor:T680 Antecedent:T423
R61	Anaphora Anaphor:T680 Antecedent:T38
R62	Anaphora Anaphor:T680 Antecedent:T34
R63	Anaphora Anaphor:T680 Antecedent:T309
R64	Anaphora Anaphor:T680 Antecedent:T302
R65	Anaphora Anaphor:T680 Antecedent:T307
R66	Anaphora Anaphor:T680 Antecedent:T300
R67	Anaphora Anaphor:T680 Antecedent:T36
T5	Drug_Class 995 1029	cation transport system inhibitors
T17	Drug 1030 1040	cimetidine
T19	Drug 1107 1119	ketoconazole
T47	Drug 1042 1054;1065 1101	trimethoprim in combination with sulfamethoxazole
T20	Drug 1125 1132	TIKOSYN
T15	Drug 978 987	verapamil
T21	Drug 1264 1274	dofetilide
T31	Drug_Class 1323 1370	inhibitors of the renal cation transport system
T22	Drug 1379 1395	prochlorperazine
T23	Drug 1400 1409	megestrol
T24	Drug 1444 1451	TIKOSYN
T28	Drug 1553 1560	TIKOSYN
T18	Drug 1476 1495;1506 1546	hydrochlorothiazide in combinations such as with triamterene
T29	Drug 1677 1687	dofetilide
T84	Drug 6187 6197	dofetilide
T54	Drug_Class 6138 6162	inhibitor of this system
T79	Drug 5849 5859	dofetilide
T56	Drug_Class 5902 5942;5964 5977	drugs that interfere with the metabolism of dofetilide
T59	Drug 6352 6362	dofetilide
T60	Drug_Class 6288 6314	inhibitors of this process
T70	Drug 6437 6449	trimethoprim
T88	Drug 6425 6435	cimetidine
T89	Drug 6455 6467	ketoconazole
T90	Drug 6511 6521	dofetilide
T80	Drug_Class 6541 6574	renal cation transport inhibitors
T75	Drug 7060 7067	TIKOSYN
T86	Drug_Class 7094 7128	drugs that prolong the QT interval
T108	Drug_Class 7323 7354	Class III antiarrhythmic agents
T91	Drug_Class 7312 7319;7333 7354	Class I antiarrhythmic agents
T109	Drug 7425 7432	TIKOSYN
T140	Drug 9933 9949	prochlorperazine
T150	Drug_Class 10273 10298	tricyclic antidepressants
T138	Drug 9801 9811	cimetidine
T142	Drug 10032 10044	ketoconazole
T101	Drug_Class 10081 10100;10111 10151	hydrochlorothiazide in combinations such as with triamterene
T99	Drug 9838 9850;9860 9896	trimethoprim in combination with sulfamethoxazole
T137	Drug 9785 9792	TIKOSYN
T147	Drug_Class 10253 10267	phenothiazines
T141	Drug 9986 9995	megestrol
T145	Drug_Class 10185 10205	cardiovascular drugs
T146	Drug 10218 10227	verapamil
T102	Drug 11536 11546	cimetidine
T173	Drug 11567 11577	Cimetidine
T175	Drug 11703 11713	dofetilide
T174	Drug 11643 11650	TIKOSYN
T176	Drug 11736 11746	Cimetidine
T178	Drug 11811 11821	dofetilide
T119	Drug 12178 12185	TIKOSYN
T118	Drug 12243 12252	verapamil
T190	Drug 12307 12316	verapamil
T191	Drug 12342 12352	dofetilide
T189	Drug 12294 12301	TIKOSYN
T194	Drug 12585 12595	dofetilide
T193	Drug 12570 12579	verapamil
T123	Drug 12728 12740	ketoconazole
T200	Drug 12912 12922	dofetilide
T199	Drug 12852 12859	TIKOSYN
T198	Drug 12761 12773	Ketoconazole
T133	Drug 13123 13135;13145 13181	trimethoprim in combination with sulfamethoxazole
T149	Drug 13202 13214;13222 13241;13249 13265	Trimethoprim in combination with sulfamethoxazole
T207	Drug 13351 13361	dofetilide
T206	Drug 13291 13298	TIKOSYN
T157	Drug 13505 13509;13519 13550	HCTZ in combination with triamterene
T219	Drug 13747 13751	HCTZ
T220	Drug 13759 13769	dofetilide
T223	Drug 13982 13992	dofetilide
T221	Drug 13944 13980	HCTZ in combination with triamterene
T197	Drug_Class 14798 14836	Inhibitors of renal cationic secretion
T201	Drug 14862 14869	TIKOSYN
T238	Drug 15037 15047	dofetilide
T204	Drug_Class 14884 14931	drugs that are actively secreted via this route
T235	Drug 14939 14950	triamterene
T236	Drug 14952 14961	metformin
T237	Drug 14967 14976	amiloride
T242	Drug 15214 15224	dofetilide
T233	Drug_Class 15155 15189	Inhibitors of the CYP3A4 isoenzyme
T256	Drug 15556 15566	dofetilide
T241	Drug_Class 15235 15263	Inhibitors of this isoenzyme
T255	Drug 15515 15522	TIKOSYN
T245	Drug_Class 15271 15292	macrolide antibiotics
T246	Drug_Class 15294 15317	azole antifungal agents
T247	Drug_Class 15319 15338	protease inhibitors
T248	Drug_Class 15340 15369	serotonin reuptake inhibitors
T249	Drug 15371 15381	amiodarone
T250	Drug_Class 15383 15395	cannabinoids
T251	Drug 15397 15406	diltiazem
T269	Substance 15408 15424	grapefruit juice
T268	Drug 15426 15436	nefazadone
T252	Drug 15438 15449	norfloxacin
T253	Drug 15451 15458	quinine
T254	Drug 15460 15471	zafirlukast
T262	Drug 15947 15954	digoxin
T263	Drug 15960 15970	dofetilide
T298	Drug 17696 17706	dofetilide
T299	Drug_Class 17745 17763	thiazide diuretics
T288	Drug_Class 17768 17814	inhibitors of tubular organic cation transport
T4	Drug_Class 7193 7207	phenothiazines
T7	Drug 7209 7218	cisapride
T8	Drug 7220 7228	bepridil
T9	Drug_Class 7230 7255	tricyclic antidepressants
T11	Drug_Class 7265 7280	oral macrolides
T12	Drug_Class 7294 7310	fluoroquinolones
T300	Drug_Class 17450 17496	inhibitors of tubular organic cation transport
T301	Drug_Class 17181 17205	calcium channel blockers
T302	Drug_Class 17386 17413	potassium sparing diuretics
T303	Drug_Class 17277 17297	inhibitors of CYP3A4
T304	Drug_Class 17242 17260	inducers of CYP3A4
T305	Drug_Class 15596 15615	inhibitor of CYP3A4
T306	Drug_Class 17144 17158	ACE inhibitors
T307	Drug_Class 17415 17433	thiazide diuretics
T308	Drug_Class 17207 17220	beta blockers
T309	Drug_Class 17370 17384	loop diuretics
T310	Drug_Class 7026 7047	Antiarrhythmic Agents
T311	Drug_Class 17160 17179	oral anticoagulants
T312	Drug_Class 6619 6648	Potassium-Depleting Diuretics
T313	Drug_Class 6713 6742	potassium-depleting diuretics
T314	Drug_Class 17222 17240	cardiac glycosides
T315	Drug 7515 7530	oral amiodarone
T316	Drug 12188 12197	Verapamil
T317	Drug 15788 15795	Digoxin
T318	Drug 15891 15898	digoxin
T319	Drug 16173 16180	digoxin
T320	Drug 16303 16310	digoxin
T321	Drug_Class 14352 14361	diuretics
T322	Drug_Class 14463 14472	diuretics
T323	Drug_Class 14522 14531	diuretics
T324	Drug_Class 13697 13705	diuretic
T325	Drug 13392 13411	Hydrochlorothiazide
T326	Drug 16375 16385	amlodipine
T327	Drug 16800 16811	propranolol
T328	Drug 13448 13459	Triamterene
T329	Drug 13593 13604	triamterene
T330	Drug 10486 10496	cimetidine
T331	Drug 11470 11480	Cimetidine
T332	Drug 11915 11925	cimetidine
T333	Drug 12101 12111	cimetidine
T334	Drug 12660 12672	Ketoconazole
T335	Drug 16387 16396	phenytoin
T336	Drug 16833 16842	phenytoin
T337	Drug 7545 7555	amiodarone
T338	Drug 7586 7596	amiodarone
T339	Drug 46 56	dofetilide
T340	Drug 1873 1883	dofetilide
T341	Drug 2121 2131	dofetilide
T342	Drug 2210 2220	dofetilide
T343	Drug 2253 2263	dofetilide
T344	Drug 2391 2401	dofetilide
T345	Drug 2526 2536	dofetilide
T346	Drug 2879 2889	dofetilide
T347	Drug 2986 2996	dofetilide
T348	Drug 3170 3180	dofetilide
T349	Drug 6224 6234	dofetilide
T350	Drug 7711 7721	dofetilide
T351	Drug 8124 8134	dofetilide
T352	Drug 8535 8545	dofetilide
T353	Drug 12409 12419	dofetilide
T354	Drug 14226 14236	dofetilide
T355	Drug 14736 14746	Dofetilide
T356	Drug 15056 15066	Dofetilide
T357	Drug 15575 15585	Dofetilide
T358	Drug 17092 17102	dofetilide
T359	Drug 17885 17895	Dofetilide
T360	Drug 18126 18136	dofetilide
T361	Drug 18252 18262	dofetilide
T362	Drug 18351 18361	dofetilide
T363	Drug 18510 18520	dofetilide
T364	Drug 18645 18655	dofetilide
T365	Drug 19134 19144	dofetilide
T366	Drug 19256 19266	Dofetilide
T367	Drug 20084 20094	dofetilide
T368	Drug 20337 20347	dofetilide
T369	Drug 20531 20541	dofetilide
T370	Drug 26 33	Tikosyn
T371	Drug 142 149	TIKOSYN
T372	Drug 414 421	TIKOSYN
T373	Drug 499 506	TIKOSYN
T374	Drug 602 609	TIKOSYN
T375	Drug 688 695	TIKOSYN
T376	Drug 837 844	TIKOSYN
T377	Drug 1740 1747	TIKOSYN
T378	Drug 1864 1871	TIKOSYN
T379	Drug 3222 3229	TIKOSYN
T380	Drug 3478 3485	TIKOSYN
T381	Drug 4198 4205	TIKOSYN
T382	Drug 4603 4610	TIKOSYN
T383	Drug 4823 4830	TIKOSYN
T384	Drug 5059 5066	TIKOSYN
T385	Drug 5223 5230	TIKOSYN
T386	Drug 5349 5356	TIKOSYN
T387	Drug 5672 5679	TIKOSYN
T388	Drug 6036 6043	TIKOSYN
T389	Drug 6871 6878	TIKOSYN
T390	Drug 6939 6946	TIKOSYN
T391	Drug 7454 7461	TIKOSYN
T392	Drug 7820 7827	TIKOSYN
T393	Drug 8372 8379	TIKOSYN
T394	Drug 8613 8620	TIKOSYN
T395	Drug 8872 8879	TIKOSYN
T396	Drug 9139 9146	TIKOSYN
T397	Drug 9397 9404	TIKOSYN
T398	Drug 10339 10346	TIKOSYN
T399	Drug 10556 10563	TIKOSYN
T400	Drug 10843 10850	TIKOSYN
T401	Drug 11949 11956	TIKOSYN
T402	Drug 13643 13650	TIKOSYN
T403	Drug 14340 14347	TIKOSYN
T404	Drug 14610 14617	TIKOSYN
T405	Drug 15843 15850	TIKOSYN
T406	Drug 16094 16101	TIKOSYN
T407	Drug 16627 16634	TIKOSYN
T408	Drug 16695 16702	TIKOSYN
T409	Drug 20633 20640	TIKOSYN
T410	Drug 20713 20720	TIKOSYN
T411	Drug 21150 21157	TIKOSYN
T412	Drug 21210 21217	TIKOSYN
T413	Drug 21328 21335	TIKOSYN
T414	Drug 21568 21575	TIKOSYN
T415	Drug 21735 21742	TIKOSYN
T416	Drug 21823 21830	TIKOSYN
T417	Drug 16763 16771	warfarin
T418	Drug 16575 16587	theophylline
T419	Drug 16844 16856	theophylline
T420	Drug 10380 10390	omeprazole
T421	Drug 12002 12012	omeprazole
T422	Drug 16421 16431	omeprazole
T423	Drug_Class 17344 17352	nitrates
T424	Drug 13009 13021	Trimethoprim
T425	Drug 13413 13417	HCTZ
T426	Drug 13571 13575	HCTZ
T427	Drug 13588 13592	HCTZ
T428	Substance 6793 6802	Potassium
T429	Substance 14274 14283	potassium
T430	Substance 14502 14511	potassium
T431	Drug_Class 10407 10415	antacids
T432	Drug_Class 12029 12037	antacids
T433	Drug_Class 9098 9108	Medication
T434	Drug_Class 9198 9208	Medication
T435	Drug_Class 9613 9623	medication
T436	Drug_Class 10753 10763	medication
T437	Drug_Class 16326 16336	medication
T438	Drug 10392 10402	ranitidine
T439	Drug 12014 12024	ranitidine
T440	Drug 16409 16419	ranitidine
T441	Drug_Class 9560 9571	Medications
T442	Drug_Class 14559 14570	medications
T443	Drug_Class 17038 17049	medications
T444	Drug_Class 17116 17127	medications
T32	Drug_Class 17262 17272;17288 17297	substrates of CYP3A4
T33	Drug_Class 17314 17342	inhibitors of P-glycoprotein
T34	Drug_Class 17354 17368	sulphonylureas
T35	Drug_Class 17299 17309;17325 17342	substrates of P-glycoprotein
T36	Drug_Class 17435 17445;17461 17496	substrates of tubular organic cation transport
T38	Drug_Class 17502 17522	QTc-prolonging drugs
T2	Substance 6104 6130	the cytochrome P450 system
T37	Drug_Class 16433 16460	hormone replacement therapy
T733	SPAN 3949 3957	patients
T734	SPAN 10565 10573	Patients
T735	SPAN 10860 10868	Patients
T736	SPAN 20558 20566	Patients
T464	ZeroArticleNP 0 10	Drug Label
T465	ZeroArticleNP 15 33	drug brand Tikosyn
T466	DefiniteNP 72 80	the risk
T467	IndefiniteNP 171 180	a minimum
T468	IndefiniteNP 194 204	a facility
T469	IndefiniteNP 732 754	a baseline QT interval
T470	DistributivePronoun 1212 1216	each
T471	DefiniteNP 955 974	The concomitant use
T472	DefiniteNP 991 1029	the cation transport system inhibitors
T473	IndefiniteNP 1238 1260	a substantial increase
T474	DemonstrativeNP 1220 1231	these drugs
T475	ZeroArticleNP 1042 1054;1065 1101	trimethoprim in combination with sulfamethoxazole
T476	IndefiniteNP 1311 1370	other known inhibitors of the renal cation transport system
T477	DefiniteNP 1453 1472	The concomitant use
T478	DemonstrativeNP 1476 1495;1506 1546	hydrochlorothiazide in combinations such as with triamterene
T479	DefiniteNP 1817 1825	the drug
T480	IndefiniteNP 1789 1813	a known hypersensitivity
T481	IndefiniteNP 1993 2030	a polymorphic ventricular tachycardia
T482	ZeroArticleNP 2202 2238	certain dofetilide drug interactions
T483	DefiniteNP 2286 2294	The risk
T484	DefiniteNP 2332 2356	the plasma concentration
T485	DefiniteNP 2379 2406	the initial dofetilide dose
T486	DefiniteNP 2459 2466	the ECG
T487	DefiniteNP 2494 2509	the QT interval
T488	DefiniteNP 2685 2697	the presence
T489	DefiniteNP 2722 2736	the management
T490	IndefiniteNP 2591 2600	a minimum
T491	IndefiniteNP 2618 2628	a facility
T492	DefiniteNP 2788 2812	the creatinine clearance
T493	DefiniteNP 2861 2875	the first dose
T494	IndefiniteNP 2817 2829	all patients
T495	PossessivePronoun 3117 3129	its relation
T496	DefiniteNP 2974 2982	The risk
T497	DefiniteNP 3097 3112	the QT interval
T498	DefiniteNP 3133 3166	the dose and plasma concentration
T499	DefiniteNP 3198 3211	the frequency
T500	DefiniteNP 3282 3308	the overall mortality rate
T501	DefiniteNP 3427 3442	The QT interval
T502	DefiniteNP 3650 3692	the supraventricular arrhythmia population
T503	DefiniteNP 3752 3773	the overall incidence
T504	DefiniteNP 3806 3819	The frequency
T505	PossessivePronoun 3982 4002	their renal function
T506	DefiniteNP 3916 3924	the rate
T507	DefiniteNP 4122 4134	The majority
T508	DefiniteNP 4138 4150	the episodes
T509	DefiniteNP 4174 4194	the first three days
T510	DefiniteNP 4231 4242	the studies
T511	DefiniteNP 4370 4398	the DIAMOND AF subpopulation
T512	ZeroArticleNP 4198 4213	TIKOSYN therapy
T513	DefiniteNP 4458 4500	the supraventricular arrhythmia population
T514	DefiniteNP 4631 4648	the placebo group
T515	IndefiniteNP 4416 4442	a pooled survival analysis
T516	DefiniteNP 4760 4778	the point estimate
T517	DefiniteNP 4782 4798	the hazard ratio
T518	DefiniteNP 4803 4821	the pooled studies
T519	ZeroArticleNP 4675 4682	therapy
T520	DefiniteNP 4868 4883	The DIAMOND CHF
T521	DemonstrativeNP 4987 5020	these large, double-blind studies
T522	IndefiniteNP 5119 5130	an analysis
T523	DefiniteNP 5294 5310	the small number
T524	DefiniteNP 5396 5424	the pooled survival analysis
T525	IndefiniteNP 5322 5341	an excess mortality
T526	PersonalPronoun 5510 5512	it
T527	DefiniteNP 5991 5999	the risk
T528	IndefiniteNP 5819 5840	a linear relationship
T529	DefiniteNP 6080 6100	the CYP3A4 isoenzyme
T530	DefiniteNP 6104 6130	the cytochrome P450 system
T531	IndefiniteNP 6062 6076	a small degree
T532	IndefiniteNP 6135 6162	an inhibitor of this system
T533	DemonstrativeNP 6282 6314	three inhibitors of this process
T534	DefiniteNP 6373 6386	The magnitude
T535	DefiniteNP 6390 6400	the effect
T536	IndefiniteNP 6537 6574	all renal cation transport inhibitors
T537	ZeroArticleNP 6619 6648	Potassium-Depleting Diuretics
T538	DefiniteNP 6755 6768	the potential
T539	ZeroArticleNP 6713 6742	potassium-depleting diuretics
T540	DefiniteNP 6827 6843	the normal range
T541	DefiniteNP 6897 6913	the normal range
T542	ZeroArticleNP 6991 6996	Drugs
T543	ZeroArticleNP 7026 7047	Antiarrhythmic Agents
T544	DefiniteNP 7049 7056	The use
T545	IndefiniteNP 7088 7128	other drugs that prolong the QT interval
T546	DemonstrativeNP 7174 7184	Such drugs
T547	ZeroArticleNP 7312 7319;7323 7354	Class I Class III antiarrhythmic agents
T548	DefiniteNP 7677 7707	The overall systemic clearance
T549	DefiniteNP 7808 7816	The dose
T550	DemonstrativeNP 8020 8034	these patients
T551	DefiniteNP 8078 8095	the effectiveness
T552	DemonstrativeNP 8422 8436	these patients
T553	IndefiniteNP 8512 8531	any adverse effects
T554	DefiniteNP 8800 8827	the Phase 3 clinical trials
T555	IndefiniteNP 8835 8858	a functioning pacemaker
T556	DefiniteNP 9094 9114	the Medication Guide
T557	PersonalPronoun 9226 9228	it
T558	DefiniteNP 9156 9167	the patient
T559	DefiniteNP 9194 9214	the Medication Guide
T560	DefiniteNP 9266 9277	the patient
T561	DistributiveNP 9229 9246	each time therapy
T562	ZeroArticleNP 9139 9154	TIKOSYN therapy
T563	DefiniteNP 9300 9311	The patient
T564	DefiniteNP 9342 9350	the need
T565	DefiniteNP 9371 9393	the recommended dosing
T566	DefiniteNP 9409 9422	the potential
T567	DefiniteNP 9450 9458	the need
T568	DefiniteNP 9521 9529	the risk
T569	ZeroArticleNP 9427 9444	drug interactions
T570	ZeroArticleNP 9560 9571	Medications
T571	DefiniteNP 9761 9781	the pharmacokinetics
T572	IndefiniteNP 9647 9667	all over-the-counter
T573	IndefiniteNP 10179 10205	other cardiovascular drugs
T574	DemonstrativeNP 10081 10100;10111 10151	hydrochlorothiazide in combinations such as with triamterene
T575	ZeroArticleNP 9603 9631	patients' medication history
T576	ZeroArticleNP 9687 9714	herbal/natural preparations
T577	ZeroArticleNP 9732 9744	preparations
T578	ZeroArticleNP 9838 9850;9860 9896	trimethoprim in combination with sulfamethoxazole
T579	DefiniteNP 10532 10552	the pharmacokinetics
T580	IndefiniteNP 10319 10328	a patient
T581	DemonstrativeNP 10501 10513	these agents
T582	ZeroArticleNP 10360 10378	anti-ulcer therapy
T583	PossessivePronoun 10605 10632	their health care providers
T584	IndefiniteNP 10636 10646	any change
T585	DefiniteNP 10783 10794	the patient
T586	DefiniteNP 10807 10831	the health care provider
T587	IndefiniteNP 10704 10713	a patient
T588	IndefiniteNP 10747 10763	a new medication
T589	IndefiniteNP 10768 10781	any condition
T590	ZeroArticleNP 10835 10858	ongoing TIKOSYN therapy
T591	PossessivePronoun 10892 10918	their health care provider
T592	IndefiniteNP 10953 10987	a new over-the-counter preparation
T593	PossessivePronoun 11247 11273	their health care provider
T594	DemonstrativeNP 11196 11212	these conditions
T595	DefiniteNP 11337 11350	the next dose
T596	IndefiniteNP 11354 11360	a dose
T597	DefiniteNP 11372 11385	The next dose
T598	DefiniteNP 11405 11419	the usual time
T599	IndefiniteNP 11793 11807	a 13% increase
T600	PersonalPronoun 11981 11983	it
T601	DefiniteNP 12147 12174	the pharmacokinetic profile
T602	IndefiniteNP 11930 11939	a patient
T603	DemonstrativeNP 12116 12128	these agents
T604	ZeroArticleNP 11961 11979	anti-ulcer therapy
T605	DefiniteNP 12471 12502	the supraventricular arrhythmia
T606	DefiniteNP 12536 12566	the concomitant administration
T607	IndefiniteNP 12456 12467	an analysis
T608	IndefiniteNP 12616 12635	a higher occurrence
T609	ZeroArticleNP 13034 13045	Combination
T610	ZeroArticleNP 13123 13135;13145 13181	trimethoprim in combination with sulfamethoxazole
T611	ZeroArticleNP 13202 13214;13222 13241;13249 13265	Trimethoprim in combination with sulfamethoxazole
T612	ZeroArticleNP 13215 13265	160 mg in combination with 800 mg sulfamethoxazole
T613	ZeroArticleNP 13431 13442	Combination
T614	ZeroArticleNP 13505 13509;13519 13550	HCTZ in combination with triamterene
T615	ZeroArticleNP 13697 13709	diuretic use
T616	DefiniteNP 13817 13843	the pharmacodynamic effect
T617	ZeroArticleNP 13944 13980	HCTZ in combination with triamterene
T618	DefiniteNP 14040 14066	the pharmacodynamic effect
T619	DefiniteNP 14145 14172	The pharmacodynamic effects
T620	DefiniteNP 14210 14222	the increase
T621	DefiniteNP 14250 14264	the reductions
T622	IndefiniteNP 14193 14206	a combination
T623	DefiniteNP 14288 14306	the DIAMOND trials
T624	DefiniteNP 14423 14440	the 1248 patients
T625	ZeroArticleNP 14352 14361	diuretics
T626	ZeroArticleNP 14463 14472	diuretics
T627	PossessivePronoun 14541 14570	their concomitant medications
T628	DefiniteNP 14477 14493	the 229 patients
T629	DefiniteNP 14574 14592	the DIAMOND trials
T630	DefiniteNP 14594 14606	the patients
T631	IndefiniteNP 14622 14663	a non-significantly reduced relative risk
T632	ZeroArticleNP 14512 14531	depleting diuretics
T633	DefiniteNP 14764 14774	the kidney
T634	ZeroArticleNP 14798 14836	Inhibitors of renal cationic secretion
T635	PersonalPronoun 15017 15021	they
T636	DemonstrativeNP 14884 14931	drugs that are actively secreted via this route
T637	DefiniteNP 15103 15123	the CYP3A4 isoenzyme
T638	DefiniteNP 15127 15153	the cytochrome P450 system
T639	IndefiniteNP 15085 15099	a small extent
T640	PersonalPronoun 15526 15530	they
T641	DemonstrativeNP 15235 15263	Inhibitors of this isoenzyme
T642	ZeroArticleNP 15294 15317	azole antifungal agents
T643	ZeroArticleNP 15319 15338	protease inhibitors
T644	ZeroArticleNP 15340 15369	serotonin reuptake inhibitors
T645	IndefiniteNP 15593 15615	an inhibitor of CYP3A4
T646	IndefiniteNP 15623 15639	other cytochrome
T647	ZeroArticleNP 15640 15655	P450 isoenzymes
T648	ZeroArticleNP 15721 15726	drugs
T649	IndefiniteNP 15751 15761	Other Drug
T650	DefiniteNP 15867 15887	the pharmacokinetics
T651	DefiniteNP 15913 15943	the concomitant administration
T652	IndefiniteNP 15991 16010	a higher occurrence
T653	PersonalPronoun 16034 16036	It
T654	DefiniteNP 16105 16117	the presence
T655	IndefiniteNP 16074 16088	an interaction
T656	IndefiniteNP 16210 16229	a known risk factor
T657	ZeroArticleNP 16314 16336	concomitant medication
T658	DefiniteNP 16603 16623	the pharmacokinetics
T659	IndefiniteNP 16462 16475	a combination
T660	ZeroArticleNP 16375 16460	amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy
T661	DefiniteNP 16719 16739	the pharmacokinetics
T662	DefiniteNP 16776 16796	the pharmacokinetics
T663	DefiniteNP 17011 17022	the effects
T664	ZeroArticleNP 17026 17049	concomitant medications
T665	ZeroArticleNP 17104 17127	Concomitant medications
T666	ZeroArticleNP 17144 17158	ACE inhibitors
T667	ZeroArticleNP 17160 17179	oral anticoagulants
T668	ZeroArticleNP 17181 17205	calcium channel blockers
T669	ZeroArticleNP 17207 17220	beta blockers
T670	ZeroArticleNP 17242 17260	inducers of CYP3A4
T671	ZeroArticleNP 17262 17272;17277 17297	substrates inhibitors of CYP3A4
T672	ZeroArticleNP 17299 17309;17314 17342	substrates inhibitors of P-glycoprotein
T673	ZeroArticleNP 17370 17384	loop diuretics
T674	ZeroArticleNP 17386 17413	potassium sparing diuretics
T675	ZeroArticleNP 17415 17433	thiazide diuretics
T676	ZeroArticleNP 17435 17445;17450 17496	substrates inhibitors of tubular organic cation transport
T677	ZeroArticleNP 17502 17522	QTc-prolonging drugs
T678	DefiniteNP 17607 17616	the study
T679	IndefiniteNP 17591 17603	any occasion
T680	DemonstrativeNP 17569 17586	these medications
T681	ZeroArticleNP 17632 17643	medications
T682	DefiniteNP 17673 17692	The mean clearances
T683	ZeroArticleNP 17745 17763	thiazide diuretics
T684	ZeroArticleNP 17768 17814	inhibitors of tubular organic cation transport
T685	DefiniteNP 17969 17997	the bacterial mutation assay
T686	DefiniteNP 18140 18148	the diet
T687	IndefiniteNP 18185 18207	an increased incidence
T688	DefiniteNP 18240 18267	The highest dofetilide dose
T689	DefiniteNP 18432 18443	the maximum
T690	DemonstrativeNP 18378 18389	these doses
T691	IndefiniteNP 18597 18603	a dose
T692	IndefiniteNP 18638 18659	a mean dofetilide AUC
T693	IndefiniteNP 18787 18798	a reduction
T694	IndefiniteNP 18847 18860	other studies
T695	DemonstrativeNP 19014 19028	these findings
T696	DemonstrativeNP 19066 19081	these 3 species
T697	DistributivePronoun 19662 19668	either
T698	DefiniteNP 19497 19511	the occurrence
T699	DefiniteNP 19580 19587	the rat
T700	IndefiniteNP 19438 19460	an increased incidence
T701	DistributiveNP 19662 19676	either species
T702	ZeroArticleNP 19626 19640	drug treatment
T703	DefiniteNP 19705 19742	The clearest drug-effect associations
T704	DefiniteNP 19931 19938	the rat
T705	DefiniteNP 19991 20000	the mouse
T706	DistributiveNP 19790 19802	both species
T707	DefiniteNP 20002 20009	The "no
T708	DistributiveNP 20043 20055	both species
T709	DefiniteNP 20075 20099	The mean dofetilide AUCs
T710	DefiniteNP 20124 20131	the rat
T711	DefiniteNP 20177 20188	the maximum
T712	DefiniteNP 20221 20241	the likely human AUC
T713	DemonstrativeNP 20111 20120	this dose
T714	DefiniteNP 20400 20411	the benefit
T715	DefiniteNP 20415 20426	the patient
T716	DefiniteNP 20437 20455	the potential risk
T717	DefiniteNP 20459 20468	the fetus
T718	DefiniteNP 20515 20527	the presence
T719	PersonalPronoun 20617 20621	they
T720	IndefiniteNP 20604 20613	an infant
T721	DefiniteNP 20661 20677	the total number
T722	IndefiniteNP 20948 20978	a reduced creatinine clearance
T723	DefiniteNP 21101 21113	the patients
T724	DefiniteNP 21117 21146	the placebo-controlled trials
T725	IndefiniteNP 21167 21178	other drugs
T726	IndefiniteNP 21238 21252	a greater risk
T727	DefiniteNP 21324 21364	the TIKOSYN clinical development program
T728	DefiniteNP 21366 21374	the risk
T729	DefiniteNP 21480 21493	the incidence
T730	IndefiniteNP 21497 21526	other ventricular arrhythmias
T731	DemonstrativeNP 21652 21661	this risk
T732	DefiniteNP 21791 21801	The safety
